Precision cancer diagnostics
Navignostics has raised €8.6M across 2 funding rounds from 2 investors, most recently a round in Nov 2022. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-11-11 | Other | €7.6M | Bruker Invest | View deal → |
| 2022-09-02 | Debt | €1.0M | UZH Life Science Fund | View deal → |
